Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study

Background: COVID-19 has spread globally with remarkable speed, and currently, there is limited data available exploring any aspect of the intersection between HIV and SARSCoV- 2 co-infection. Objective: To estimate the prevalence of clinical symptoms associated with COVID-19 among people living with HIV (PLWH) in Tehran, Iran. Design: Cross-sectional study. Methods: A total of 200 PLWH were recruited through the positive club via sampling, and completed the symptom-based questionnaire for COVID-19, which was delivered by trained peers. Results: Of 200 participants, respiratory symptoms, including cough, sputum, and shortness of breath, were the most prevalent among participants, but only one person developed symptoms collectively suggested COVID-19 and sought treatments. Conclusions: It appears that existing infection with HIV or receiving antiretroviral treatment (ART) might reduce the susceptibility to the infection with SARS-CoV-2 or decrease the severity of the infection acquired. Further research is needed to understand causal mechanisms.

Download Full-text

Impact of high visceral adiposity index associated with metabolic syndrome on erectile function in sexually active men: results of a cross‐sectional study

International Journal of Clinical Practice ◽

10.1111/ijcp.14111 ◽

2021 ◽

Author(s):

Mustafa Suat Bolat ◽

Mustafa Latif Ozbek ◽

Bekir Şahin ◽

Merve Yılmaz ◽

Fatih Kocamanoglu ◽

...

Keyword(s):

Metabolic Syndrome ◽

Erectile Function ◽

Cross Sectional Study ◽

Visceral Adiposity ◽

Visceral Adiposity Index ◽

Sexually Active ◽

Sectional Study ◽

Cross Sectional ◽

Adiposity Index

Download Full-text

The association between dietary antioxidant quality score with metabolic syndrome and its components in Iranian adults: A cross‐sectional study

Food Science & Nutrition ◽

10.1002/fsn3.2067 ◽

2020 ◽

Author(s):

Mahshid Shahavandi ◽

Hossein Shahinfar ◽

Nastaran payande ◽

Fatemeh Sheikhhossein ◽

Kurosh Djafarian ◽

...

Keyword(s):

Metabolic Syndrome ◽

Cross Sectional Study ◽

Quality Score ◽

Sectional Study ◽

Cross Sectional ◽

Dietary Antioxidant

Download Full-text

Association of Serum Bilirubin Level with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study of 1672 Obese Children

Journal of Clinical Medicine ◽

10.3390/jcm10132812 ◽

2021 ◽

Vol 10 (13) ◽

pp. 2812

Author(s):

Cristina Bellarosa ◽

Giorgio Bedogni ◽

Annalisa Bianco ◽

Sabrina Cicolini ◽

Diana Caroli ◽

...

Keyword(s):

Metabolic Syndrome ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Serum Bilirubin ◽

Cross Sectional Study ◽

Sectional Study ◽

Obese Children ◽

Cross Sectional ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

As in adults, obesity also plays a central role in the development of metabolic syndrome (MS) in children. Non-alcoholic fatty liver disease (NAFLD) is considered a manifestation of MS. Not only MS but also NAFLD seem to be inversely associated with serum bilirubin concentrations, an important endogenous tissue protector when only mild elevated. The aim of the study was to evaluate the association between serum bilirubin levels and the prevalence of MS and NAFLD in Italian obese children and adolescents. A retrospective cross-sectional study was performed in 1672 patients aged from 5 to 18 years. Clinical and laboratory parameters were assessed. NAFLD was measured by liver ultrasonography. The study was approved by the Ethical Committee of the Istituto Auxologico Italiano (research project code 1C021_2020, acronym BILOB). MS was present in 24% and fatty liver (FL) in 38% of this population. Bilirubin was not associated with FL and MS as a whole, but it was inversely associated only with selected components of MS, i.e., large WC, high blood pressure and high triglycerides. Our data suggest that bilirubin is not protective against MS and NAFLD in the presence of severe obesity.

Download Full-text

A Cross-Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men

AIDS and Behavior ◽

10.1007/s10461-021-03373-y ◽

2021 ◽

Author(s):

Sara Gianella ◽

Rowan Saloner ◽

Genevieve Curtin ◽

Susan J. Little ◽

Anne Heaton ◽

...

Keyword(s):

Hiv Infection ◽

Small Sample Size ◽

Cross Sectional Study ◽

Small Sample ◽

Self Report ◽

Anxiety And Depression ◽

Depression And Anxiety ◽

Sectional Study ◽

Cross Sectional ◽

Study Results

AbstractThis observational cross-sectional study of 152 people with HIV (PWH) examined the effects of age and estimated duration of HIV infection (EDI) on depressive and anxiety symptoms. All participants were cisgender men and completed the Profile of Moods State (POMS), a self-report inventory of current (i.e., past week) mood states. Overall, study results confirmed higher levels of anxiety and depression in PWH compared to individuals without HIV. Age group (< 50 or ≥ 50 years) moderated the effect of EDI (< 3 or ≥ 3 years) on mood disturbance. Specifically, younger PWH with early diagnosed infection exhibited the highest levels of depression and anxiety, whereas depression and anxiety were attenuated in older PWH with early infection such that their POMS scores did not significantly differ from the HIV-negative and chronically HIV-infected groups. Despite the small sample size and other important limitations in our study design, our preliminary findings confirm previous observations that older people may have some adaptive ability to better handle the acute psychological stressors associated with recent HIV infection.

Download Full-text